Inspections, Compliance, Enforcement, and Criminal Investigations
Multi-Med, Inc. - Closed Out Letter 11/9/10
Department of Health and Human Services
|Public Health Service|
Food and Drug Administration
|New England District|
One Montvale Avenue
Stoneham, Massachusetts 02180
FAX: (781) 596-7896
November 09, 2010
Alan P. Reid, President
26 Victoria Ct.
Keene, NH 03431
Dear Mr. Reid:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter NWE-01-10W dated October 07,2009. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory
action should violations be observed during a subsequent inspection or through other means.
Amber G. Wardwell
Acting Director, Compliance Branch
New England District Office
U.S. Food & Drug Administration